Novavax Inc. (NVAX) stock forecast and price target
Price $8.53 · data as of November 13, 2026
12-month price target
Average target$14.11
Upside / downside+65.5%
Analysts9
ConsensusBuy
Low $7.00Average $14.11High $25.00
Gold marker: average target · white marker: today’s price ($8.53)
Analyst ratings
Strong buy 0Buy 5Hold 1Sell 1Strong sell 2
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-0.05 | −102.5% | $473M |
| Next fiscal year ends December 31, 2027 | $-0.45 | −125.0% | $246M |
| Next quarter ends December 31, 2026 | $0.54 | +341.8% | $216M |
| Quarter after ends March 31, 2027 | $-0.35 | — | $36M |
Consensus of the analysts covering Novavax, updated daily. In the last 30 days 1 estimates were raised and 1 lowered.
Frequently asked questions
What is the Novavax stock price target?
The average 12-month target from 9 analysts is $14.11, 65.5% above the current price of $8.53 Targets range from $7.00 to $25.00.
Is Novavax a buy according to analysts?
The consensus rating is “Buy” (5 buy, 1 hold, 1 sell, 2 strong sell). Ratings are opinions, not guarantees; this is not investment advice.
How much is Novavax expected to earn?
Analysts expect EPS of $-0.05 for the fiscal year ending December 31, 2026 and $-0.45 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.